CSIMarket


Cytokinetics Incorporated  (CYTK)
Other Ticker:  
 

Cytokinetics Incorporated

CYTK's Fundamental analysis








Cytokinetics Incorporated's sales fell by -84.97 % in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 2050

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -4.74 %

Cytokinetics Incorporated net loss deacreased by in III. Quarter 2023 year on year, Cytokinetics Incorporated net loss increased by -9.06 % in III. Quarter 2023 year on year,

More on CYTK's Growth


Cytokinetics Incorporated
realized net loss in trailing twelve months.

Cytokinetics Incorporated realized cash outflow of $ -0.06per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
353.85
PE TTM    
Company's Price to Sales ratio is at 897.84.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.47.


More on CYTK's Valuation
 
 Total Debt (Millions $) 61
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 38,688
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 6.74
 Tangible Book Value (Per Share $) -4.58

Cytokinetics Incorporated
realized net loss in trailing twelve months.

Cytokinetics Incorporated realized cash outflow of $ -0.06per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
353.85
PE TTM    
Company's Price to Sales ratio is at 897.84.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.47.


More on CYTK's Valuation

  Market Capitalization (Millions $) 7,017
  Shares Outstanding (Millions) 96
  Employees 202
  Revenues (TTM) (Millions $) 8
  Net Income (TTM) (Millions $) -527
  Cash Flow (TTM) (Millions $) -6
  Capital Exp. (TTM) (Millions $) -5
  Total Debt (Millions $) 61
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 38,688
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 6.74
  Tangible Book Value (Per Share $) -4.58

  Market Capitalization (Millions $) 7,017
  Shares Outstanding (Millions) 96
  Employees 202
  Revenues (TTM) (Millions $) 8
  Net Income (TTM) (Millions $) -527
  Cash Flow (TTM) (Millions $) -6
  Capital Exp. (TTM) (Millions $) -5





  Ratio
   Capital Ratio (MRQ) 9.28
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.01
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com